We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+37.69%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$7.48B
AUM Growth
+$1.44B
Cap. Flow
-$77.6M
Cap. Flow %
-1.04%
Top 10 Hldgs %
23.83%
Holding
336
New
58
Increased
161
Reduced
69
Closed
35

Top Buys

Rank Stock Value
1
AVLN
Avalyn Pharma
AVLN
+$39.7M
2
CDNS icon
Cadence Design Systems
CDNS
+$29.6M
3
RELY icon
Remitly
RELY
+$27.3M
4
DELL icon
Dell
DELL
+$25.5M
5
FITB
Fifth Third Bancorp
FITB
+$25.3M

Top Sells

Rank Stock Value
1
XMTR icon
Xometry
XMTR
+$57.8M
2
PLD icon
Prologis
PLD
+$56.1M
3
GH icon
Guardant Health
GH
+$44M
4
AXSM icon
Axsome Therapeutics
AXSM
+$44M
5
GLBE icon
Global E Online
GLBE
+$37.6M

Sector Composition

Rank Sector Weight
1 Healthcare 36.37%
2 Technology 22.57%
3 Industrials 20.48%
4 Energy 5.51%
5 Utilities 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZTS icon
226
Zoetis
ZTS
$30.3B
$616K 0.01%
8,413
+1,365
+19% +$129K
IDXX icon
227
Idexx Laboratories
IDXX
$40.2B
$615K 0.01%
1,147
+365
+47% +$205K
NRG icon
228
NRG Energy
NRG
$22.3B
$599K 0.01%
4,017
+730
+22% +$105K
MTG icon
229
MGIC Investment
MTG
$6.14B
$595K 0.01%
21,092
+2,439
+13% +$65K
VLO icon
230
Valero Energy
VLO
$114B
$583K 0.01%
2,188
-9,901
-82% -$2.44M
STLD icon
231
Steel Dynamics
STLD
$34.3B
$567K 0.01%
2,421
+760
+46% +$178K
ZS icon
232
Zscaler
ZS
$31.6B
$565K 0.01%
4,109
+1,024
+33% +$143K
AGX icon
233
Argan
AGX
$5.45B
$564K 0.01%
712
-110
-13% -$73.2K
FOUR icon
234
Shift4
FOUR
$3.34B
$516K 0.01%
+10,706
New +$463K
EW icon
235
Edwards Lifesciences
EW
$49.4B
$513K 0.01%
5,626
+750
+15% +$62.8K
TRI icon
236
Thomson Reuters
TRI
$44.5B
$503K 0.01%
+6,081
New +$531K
TYL icon
237
Tyler Technologies
TYL
$14.5B
$481K 0.01%
1,654
+193
+13% +$61K
ARM icon
238
Arm
ARM
$258B
$476K 0.01%
+1,345
New +$358K
STRL icon
239
Sterling Infrastructure
STRL
$14B
$468K 0.01%
575
-144
-20% -$101K
VRSK icon
240
Verisk Analytics
VRSK
$23.4B
$461K 0.01%
+2,575
New +$454K
DECK icon
241
Deckers Outdoor
DECK
$10.6B
$457K 0.01%
4,517
+709
+19% +$74.7K
ALNY icon
242
Alnylam Pharmaceuticals
ALNY
$31.9B
$448K 0.01%
1,526
+415
+37% +$125K
TOL icon
243
Toll Brothers
TOL
$12.4B
$444K 0.01%
2,695
+336
+14% +$47.8K
PEG icon
244
Public Service Enterprise Group
PEG
$35.1B
$444K 0.01%
5,387
+625
+13% +$49.9K
OTIS icon
245
Otis Worldwide
OTIS
$26.1B
$443K 0.01%
6,078
+852
+16% +$63.6K
D icon
246
Dominion Energy
D
$56.2B
$441K 0.01%
6,371
+583
+10% +$37.9K
MGA icon
247
Magna International
MGA
$17B
$406K 0.01%
6,265
+660
+12% +$41.2K
GEHC icon
248
GE HealthCare
GEHC
$28.9B
$405K 0.01%
+6,233
New +$410K
CP icon
249
Canadian Pacific Kansas City
CP
$78.3B
$403K 0.01%
4,636
+824
+22% +$70.6K
PTGX icon
250
Protagonist Therapeutics
PTGX
$9.28B
$400K 0.01%
3,287
+492
+18% +$51.4K
8 9
10
11 12

Similar funds

S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Eventide Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Eventide Asset Management held 336 positions worth $7.48B, up 24% from $6.05B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q2 2026 filing shows 58 new, 161 increased, 69 reduced and 35 closed positions. Its largest new stake was Avalyn Pharma: 1,375,486 shares worth $45.3M. The largest sale was Xometry, an estimated $57.8M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q2 2026 buy was Avalyn Pharma: 1,375,486 shares worth $45.3M.
  • Eventide Asset Management added most to Cadence Design Systems in Q2 2026, an estimated $29.6M increase.
  • Eventide Asset Management's biggest Q2 2026 reduction was Xometry, cutting an estimated $57.8M.
  • Eventide Asset Management fully exited Prologis in Q2 2026, selling an estimated $56.1M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $7.48B portfolio in Q2 2026.
  • Eventide Asset Management opened 58 new positions and closed 35 in Q2 2026.
  • Eventide Asset Management's portfolio value rose 24% quarter-over-quarter to $7.48B.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.